MoH, German Embassy launch pharmaceutical innovations and analysis centre

Health Ministry Chief Administrative Secretary (CAS), Dr Rashid Aman and Deputy Ambassador, Germany Embassy in Kenya, Thomas Wimmer on Friday launched the Centre of Excellence in Pharmaceutical Innovations and Analysis and the Dual Vocational Training for Pharmaceutical Production Specialists at USIU-Africa.

“Today’s celebration demonstrates that the School of Pharmacy and Health Sciences of USIU-Africa is alive to current, emerging and future market demands by the sector and is innovating to respond,” Dr Aman said.

Among the initiatives is the launch of a short course on immunization and vaccine management in collaboration with the Pharmaceutical Society of Kenya for capacity building of healthcare providers to enhance the safe and effective deployment of vaccines.

The CAS noted that through a multi-institution collaborative effort, USIU – Africa has also initiated the development of a natural product-based supplement that is currently under review for application in home-based COVID-19 patient care.

“These efforts that contribute to promoting quality healthcare for all deserve to applaud,” said the CAS.

The Kenya Pharmaceutical Industry 2020 Diagnostic Report commissioned by World Bank IFC found that Kenya’s pharma industry is the largest in the Common Market for the East & Southern Africa region. Despite this, Kenya imports about 70% of the requirement of its pharmaceuticals.

Dr Aman observed that the challenges that face the pharmaceutical industry in Kenya are known and recommended that the cost of production, taxation and regulatory regimes need to be reviewed and addressed to provide a competitive edge to local manufacturing.

The CAS said the Government is committed to instituting and executing supportive legal, policy, and regulatory frameworks to create an enabling environment for pharmaceutical manufacturing to thrive.

Dr Aman further noted that the Ministry of Health has developed a national pharmaceutical development strategy to promote local production, research, and innovations of essential Health Products and technologies.

“The policy proposals of this strategy align with the national industrialization policy and regional and international efforts for increasing access to quality and affordable essential HPT,” he noted.

The CAS said the ministry is open to Public-Private Partnerships that will progress the collective efforts not only toward fighting covid-19 and future pandemics but also in ensuring that Kenyans have access to high-quality and affordable medicines and vaccines.

  

Latest posts

21 injured in Kisii road accident

Christine Muchira

Haematologists, oncologists advocate for dedicated cancer research infrastructure and funding

KBC Digital

Engineers want gov’t to fast track adoption of nuclear energy

Christine Muchira

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

%d bloggers like this: